about
Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways...
Read More
8.20
1.09
(15.33%)
2.0M
XNAS Volume
XNAS 21 Jul, 2026 10:47 AM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Helus Pharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..